Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Arthritis Care & Research
|
November 1, 2023
Relationships of Work Productivity and Activity Impairment With Patient-Reported Outcomes in Ankylosing Spondylitis: Results From Two Trials
Marina Magrey, James Cheng-Chung Wei, Arne Yndestad, et al.
ACR Open Rheumatology
|
April 25, 2023
The International Map of Axial Spondyloarthritis Survey: A US Patient Perspective on Diagnosis and Burden of Disease
Marina Magrey, Jessica A Walsh, Sandra Flierl, et al.
Rheumatology Advances in Practice
|
June 30, 2025
Psychosocial burden of axial spondyloarthritis and impact of different disease domains: a systematic literature review
Denis Poddubnyy, Uta Kiltz, Abhijeet Danve, et al.
The Journal of Rheumatology
|
June 2, 2024
Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials
Atul Deodhar, Xenofon Baraliakos, Marina Magrey, et al.
Arthritis Research & Therapy
|
March 25, 2026
Risk of serious infections, myocardial infarction or stroke, venous thromboembolic events, and malignancy in patients with psoriatic arthritis treated with tofacitinib compared with biologic treatments in the United States
Marina Magrey, Milena A Gianfrancesco, Lara Fallon, et al.
Rheumatology and Therapy
|
June 23, 2023
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
Lars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, et al.
Advances in Therapy
|
July 22, 2025
Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration
Victoria Navarro-Compán, John D Reveille, Proton Rahman, et al.
Rheumatology and Therapy
|
February 23, 2023
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis
Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, et al.
Rheumatology and Therapy
|
October 15, 2022
Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
Iain B McInnes, Koji Kato, Marina Magrey, et al.
Rheumatology and Therapy
|
March 13, 2026
Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies
Xenofon Baraliakos, Louis Bessette, Kurt de Vlam, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Arthritis Care & Research
|
November 1, 2023
Relationships of Work Productivity and Activity Impairment With Patient-Reported Outcomes in Ankylosing Spondylitis: Results From Two Trials
Marina Magrey, James Cheng-Chung Wei, Arne Yndestad, et al.
ACR Open Rheumatology
|
April 25, 2023
The International Map of Axial Spondyloarthritis Survey: A US Patient Perspective on Diagnosis and Burden of Disease
Marina Magrey, Jessica A Walsh, Sandra Flierl, et al.
Rheumatology Advances in Practice
|
June 30, 2025
Psychosocial burden of axial spondyloarthritis and impact of different disease domains: a systematic literature review
Denis Poddubnyy, Uta Kiltz, Abhijeet Danve, et al.
The Journal of Rheumatology
|
June 2, 2024
Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials
Atul Deodhar, Xenofon Baraliakos, Marina Magrey, et al.
Arthritis Research & Therapy
|
March 25, 2026
Risk of serious infections, myocardial infarction or stroke, venous thromboembolic events, and malignancy in patients with psoriatic arthritis treated with tofacitinib compared with biologic treatments in the United States
Marina Magrey, Milena A Gianfrancesco, Lara Fallon, et al.
Rheumatology and Therapy
|
June 23, 2023
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
Lars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, et al.
Advances in Therapy
|
July 22, 2025
Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration
Victoria Navarro-Compán, John D Reveille, Proton Rahman, et al.
Rheumatology and Therapy
|
February 23, 2023
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis
Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, et al.
Rheumatology and Therapy
|
October 15, 2022
Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
Iain B McInnes, Koji Kato, Marina Magrey, et al.
Rheumatology and Therapy
|
March 13, 2026
Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies
Xenofon Baraliakos, Louis Bessette, Kurt de Vlam, et al.
Page
of 7